HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
ETHE1
ETHE1 persulfide dioxygenase
Chromosome 19 Β· 19q13.31
NCBI Gene: 23474Ensembl: ENSG00000105755.9HGNC: HGNC:23287UniProt: A0A0S2Z580
56PubMed Papers
21Diseases
0Drugs
98Pathogenic Variants
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
iron ion bindingprotein bindingidentical protein bindingsulfur dioxygenase activityethylmalonic encephalopathyLeigh syndromeAbnormality of the nervous systemgenetic disorder
✦AI Summary

ETHE1 (ETHE1 persulfide dioxygenase) is a mitochondrial sulfur dioxygenase that plays an essential role in hydrogen sulfide catabolism by oxidizing persulfide substrates to prevent toxic H2S accumulation 1. The enzyme catalyzes the dioxygenation of glutathione persulfide to glutathione and sulfite, working downstream of SQRDL in the sulfide oxidation pathway 2. ETHE1 contains a mononuclear iron active site with a 2-His/1-Asp ligand set and requires direct substrate binding to prime the site for oxygen activation 1. Beyond its metabolic function, ETHE1 has diverse roles in cancer biology, including inhibiting angiogenesis in colorectal cancer by promoting STAT3 dephosphorylation and reducing VEGF-A expression 3, and paradoxically promoting metastasis in triple-negative breast cancer through GCN2/eIF2Ξ±/ATF4 signaling activation 4. ETHE1 deficiency causes ethylmalonic encephalopathy, a rare autosomal recessive disorder characterized by developmental delay, seizures, and microvascular damage presenting with petechiae and purpura that can mimic meningococcemia 5. Patient fibroblasts show disrupted mitochondrial bioenergetics, increased superoxide production, and impaired ER-mitochondria communication 6, highlighting ETHE1's critical role in cellular homeostasis.

Sources cited
1
ETHE1 is a sulfur dioxygenase that catalyzes glutathione persulfide dioxygenation with a mononuclear iron active site
PMID: 30362717
2
ETHE1 is part of the sulfide oxidation unit working downstream of SQRDL in H2S catabolism
PMID: 39643979
3
ETHE1 inhibits colorectal cancer angiogenesis by promoting STAT3 dephosphorylation and reducing VEGF-A expression
PMID: 39198402
4
ETHE1 promotes triple-negative breast cancer metastasis through GCN2/eIF2Ξ±/ATF4 signaling activation
PMID: 37834012
5
ETHE1 deficiency causes ethylmalonic encephalopathy with microvascular damage mimicking meningococcemia
PMID: 35165146
6
ETHE1 deficiency disrupts mitochondrial bioenergetics and increases superoxide production in patient fibroblasts
PMID: 31477743
Disease Associationsβ“˜21
ethylmalonic encephalopathyOpen Targets
0.84Strong
Leigh syndromeOpen Targets
0.37Weak
Abnormality of the nervous systemOpen Targets
0.27Weak
genetic disorderOpen Targets
0.19Weak
neurodegenerative diseaseOpen Targets
0.17Weak
colorectal carcinomaOpen Targets
0.09Suggestive
neoplasmOpen Targets
0.09Suggestive
ThrombocytopeniaOpen Targets
0.08Suggestive
triple-negative breast cancerOpen Targets
0.07Suggestive
thrombocytopenia 4Open Targets
0.07Suggestive
macrothrombocytopenia, isolated, 2, autosomal dominantOpen Targets
0.07Suggestive
autosomal dominant macrothrombocytopeniaOpen Targets
0.06Suggestive
platelet-type bleeding disorder 15Open Targets
0.05Suggestive
thrombocytopenia 2Open Targets
0.04Suggestive
platelet-type bleeding disorder 10Open Targets
0.04Suggestive
thrombocytopenia 7Open Targets
0.04Suggestive
bleeding disorder, platelet-type, 24Open Targets
0.04Suggestive
platelet storage pool deficiencyOpen Targets
0.04Suggestive
Platelet storage pool diseaseOpen Targets
0.04Suggestive
DIAPH1-related sensorineural hearing loss-thrombocytopenia syndromeOpen Targets
0.04Suggestive
Ethylmalonic encephalopathyUniProt
Pathogenic Variants98
NM_014297.5(ETHE1):c.505+1G>APathogenic
Ethylmalonic encephalopathy
β˜…β˜…β˜…β˜†2021
NM_014297.5(ETHE1):c.488G>A (p.Arg163Gln)Pathogenic
Ethylmalonic encephalopathy
β˜…β˜…β˜…β˜†2021β†’ Residue 163
NM_014297.5(ETHE1):c.505+1G>TPathogenic
Ethylmalonic encephalopathy
β˜…β˜…β˜…β˜†2021
NM_014297.5(ETHE1):c.604dup (p.Val202fs)Pathogenic
Ethylmalonic encephalopathy
β˜…β˜…β˜…β˜†2021β†’ Residue 202
NM_014297.5(ETHE1):c.487C>T (p.Arg163Trp)Pathogenic
Ethylmalonic encephalopathy|not provided
β˜…β˜…β˜…β˜†2021β†’ Residue 163
NM_014297.5(ETHE1):c.375+5G>APathogenic
Ethylmalonic encephalopathy
β˜…β˜…β˜†β˜†2025
NM_014297.5(ETHE1):c.595+2T>ALikely pathogenic
Ethylmalonic encephalopathy
β˜…β˜…β˜†β˜†2025
NM_014297.5(ETHE1):c.554T>G (p.Leu185Arg)Pathogenic
Ethylmalonic encephalopathy
β˜…β˜…β˜†β˜†2025β†’ Residue 185
NM_014297.5(ETHE1):c.221dup (p.Tyr74Ter)Pathogenic
not provided|Ethylmalonic encephalopathy
β˜…β˜…β˜†β˜†2025β†’ Residue 74
NM_014297.5(ETHE1):c.187C>T (p.Gln63Ter)Pathogenic
Ethylmalonic encephalopathy
β˜…β˜…β˜†β˜†2025β†’ Residue 63
NM_014297.5(ETHE1):c.586G>C (p.Asp196His)Likely pathogenic
Ethylmalonic encephalopathy
β˜…β˜…β˜†β˜†2025β†’ Residue 196
NM_014297.5(ETHE1):c.596-2A>GLikely pathogenic
Ethylmalonic encephalopathy
β˜…β˜…β˜†β˜†2025
NM_014297.5(ETHE1):c.506-2A>GLikely pathogenic
Ethylmalonic encephalopathy
β˜…β˜…β˜†β˜†2025
NM_014297.5(ETHE1):c.595+2T>GLikely pathogenic
Ethylmalonic encephalopathy|not provided
β˜…β˜…β˜†β˜†2025
NM_014297.5(ETHE1):c.79C>T (p.Gln27Ter)Pathogenic
Ethylmalonic encephalopathy
β˜…β˜…β˜†β˜†2025β†’ Residue 27
NM_014297.5(ETHE1):c.79C>A (p.Gln27Lys)Pathogenic
Ethylmalonic encephalopathy|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 27
NM_014297.5(ETHE1):c.586G>A (p.Asp196Asn)Pathogenic
Ethylmalonic encephalopathy|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 196
NM_014297.5(ETHE1):c.131_132del (p.Glu44fs)Pathogenic
Ethylmalonic encephalopathy
β˜…β˜…β˜†β˜†2025β†’ Residue 44
NM_014297.5(ETHE1):c.388del (p.Arg130fs)Pathogenic
Ethylmalonic encephalopathy
β˜…β˜…β˜†β˜†2025β†’ Residue 130
NM_014297.5(ETHE1):c.702_703del (p.Gln235fs)Pathogenic
Ethylmalonic encephalopathy
β˜…β˜…β˜†β˜†2025β†’ Residue 235
View on ClinVar β†—
Related Genes
GSTM5Shared pathway100%GSTT2Shared pathway100%NIT1Shared pathway100%GSTT2BShared pathway100%GSTT4Shared pathway100%SQORProtein interaction99%
Tissue Expression6 tissues
Liver
100%
Lung
75%
Bone Marrow
50%
Ovary
36%
Brain
23%
Heart
21%
Gene Interaction Network
Click a node to explore
ETHE1GSTM5GSTT2NIT1GSTT2BGSTT4SQOR
PROTEIN STRUCTURE
Preparing viewer…
PDB4CHL Β· 2.61 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.97LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.64 [0.43–0.97]
RankingsWhere ETHE1 stands among ~20K protein-coding genes
  • #8,064of 20,598
    Most Researched56
  • #793of 5,498
    Most Pathogenic Variants98 Β· top quartile
  • #9,203of 17,882
    Most Constrained (LOEUF)0.97
Genes detectedETHE1
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
ETHE1 dampens colorectal cancer angiogenesis by promoting TC45 Dephosphorylation of STAT3 to inhibit VEGF-A expression.
PMID: 39198402
Cell Death Dis Β· 2024
1.00
2
Emerging roles of hydrogen sulfide-metabolizing enzymes in cancer.
PMID: 39643979
Redox Rep Β· 2024
0.90
3
Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation.
PMID: 34737229
Proc Natl Acad Sci U S A Β· 2021
0.80
4
Phosphorylated FOXQ1, a novel substrate of JNK1, inhibits sorafenib-induced ferroptosis by activating ETHE1 in hepatocellular carcinoma.
PMID: 38839744
Cell Death Dis Β· 2024
0.70
5
ETHE1 and MOCS1 deficiencies: Disruption of mitochondrial bioenergetics, dynamics, redox homeostasis and endoplasmic reticulum-mitochondria crosstalk in patient fibroblasts.
PMID: 31477743
Sci Rep Β· 2019
0.60